Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 11, 2023

BUY
$75.55 - $92.52 $7,252 - $8,881
96 Added 0.4%
23,845 $0
Q3 2022

Oct 11, 2022

BUY
$74.61 - $87.26 $16,264 - $19,022
218 Added 0.93%
23,749 $1.81 Million
Q2 2022

Jul 08, 2022

SELL
$80.52 - $93.75 $34,382 - $40,031
-427 Reduced 1.78%
23,531 $1.99 Million
Q1 2022

Apr 05, 2022

BUY
$80.11 - $90.62 $1,121 - $1,268
14 Added 0.06%
23,958 $2.1 Million
Q4 2021

Jan 21, 2022

BUY
$79.7 - $88.13 $44,871 - $49,617
563 Added 2.41%
23,944 $2.09 Million
Q3 2021

Oct 06, 2021

SELL
$81.78 - $95.14 $1,717 - $1,997
-21 Reduced 0.09%
23,381 $1.91 Million
Q2 2021

Jul 02, 2021

BUY
$85.24 - $94.15 $85,666 - $94,620
1,005 Added 4.49%
23,402 $2.14 Million
Q1 2021

Apr 01, 2021

SELL
$83.5 - $98.47 $47,929 - $56,521
-574 Reduced 2.5%
22,397 $1.91 Million
Q4 2020

Jan 13, 2021

BUY
$78.07 - $94.43 $65,813 - $79,604
843 Added 3.81%
22,971 $2.17 Million
Q3 2020

Oct 02, 2020

BUY
$82.14 - $91.0 $59,222 - $65,611
721 Added 3.37%
22,128 $1.92 Million
Q2 2020

Jul 01, 2020

BUY
$80.93 - $91.1 $115,001 - $129,453
1,421 Added 7.11%
21,407 $1.87 Million
Q4 2019

Jan 02, 2020

SELL
$84.35 - $95.37 $16,110 - $18,215
-191 Reduced 0.95%
19,986 $1.89 Million
Q3 2019

Oct 01, 2019

SELL
$85.54 - $94.26 $23,437 - $25,827
-274 Reduced 1.34%
20,177 $1.75 Million
Q2 2019

Jul 01, 2019

BUY
$75.4 - $92.8 $60,772 - $74,796
806 Added 4.1%
20,451 $1.87 Million
Q1 2019

Apr 03, 2019

BUY
$75.32 - $86.15 $10,092 - $11,544
134 Added 0.69%
19,645 $1.89 Million
Q4 2018

Jan 25, 2019

BUY
$73.66 - $82.02 $25,928 - $28,871
352 Added 1.84%
19,511 $1.69 Million
Q3 2018

Oct 29, 2018

BUY
$66.94 - $77.43 $42,841 - $49,555
640 Added 3.46%
19,159 $1.65 Million
Q2 2018

Aug 10, 2018

BUY
$64.91 - $73.36 $1.2 Million - $1.36 Million
18,519 New
18,519 $1.4 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Cox Capital Mgt LLC Portfolio

Follow Cox Capital Mgt LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cox Capital Mgt LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cox Capital Mgt LLC with notifications on news.